Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002033801-24-000003
Filing Date
2024-11-04
Accepted
2024-11-04 14:01:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4767
  Complete submission text file 0002033801-24-000003.txt   6179
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87811 | Film No.: 241422528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12221 MERIT DRIVE SUITE 620 DALLAS TX 75251
Business Address
Weinstein Benjamin (Filed by) CIK: 0002033801 (see all company filings)

Type: SCHEDULE 13G/A